ABSTRACT
Branchial cleft cysts, sinuses, and fistulas are the most common congenital lateral neck lesions in children. They arise as a result of an abnormal development of the branchial arches and their corresponding ectoderm-lined branchial clefts. Of these diverse anomalies, second branchial cleft lesions are the most common, accounting for approximately 95% of all branchial arch pathologies. We describe what is to the best of our knowledge the first reported case of an ectopic tooth in a branchial cleft anomaly. The patient was a young girl who had other congenital abnormalities and syndromic features and who was eventually diagnosed with Townes-Brocks syndrome. We describe the clinical presentation, management, pathologic analysis, and postoperative outcomes of this case, and we present a brief review of Townes-Brocks syndrome.
Subject(s)
Abnormalities, Multiple/diagnosis , Anus, Imperforate/diagnosis , Branchial Region/abnormalities , Craniofacial Abnormalities/diagnosis , Hearing Loss, Sensorineural/diagnosis , Pharyngeal Diseases/diagnosis , Thumb/abnormalities , Tooth Eruption, Ectopic/diagnosis , Abnormalities, Multiple/pathology , Abnormalities, Multiple/surgery , Anus, Imperforate/pathology , Anus, Imperforate/surgery , Branchial Region/pathology , Branchial Region/surgery , Child , Craniofacial Abnormalities/pathology , Craniofacial Abnormalities/surgery , Female , Follow-Up Studies , Hearing Loss, Sensorineural/pathology , Hearing Loss, Sensorineural/surgery , Humans , Pharyngeal Diseases/pathology , Pharyngeal Diseases/surgery , Thumb/pathology , Thumb/surgery , Tooth Eruption, Ectopic/pathology , Tooth Eruption, Ectopic/surgery , Treatment OutcomeABSTRACT
BACKGROUND: Superior semicircular canal dehiscence is a recently described cause of imbalance, hearing loss, and tinnitus. Symptoms may begin after abrupt changes in intracranial or middle ear pressure. CASE: This patient presented with a 6-year history of imbalance, hearing loss, and pulsatile tinnitus beginning when she was pushing during labor. A temporal-bone computed tomography scan showed a dehiscence of the superior semicircular canal. Surgical repair of the dehiscence through the middle cranial fossa resulted in immediate resolution of the patient's symptoms, and she returned to full activity within 3 weeks. CONCLUSION: Superior semicircular canal dehiscence is recognized increasingly as a cause of multiple otologic symptoms. Obstetricians and gynecologists with patients complaining about postpartum vertigo should inquire about symptom onset and focus their questions around events during the second stage of labor. Patients with symptoms of dehiscence should be referred to a neurootologist for treatment, including possible surgical repair.
Subject(s)
Hearing Loss, Conductive/etiology , Puerperal Disorders/etiology , Semicircular Canals/pathology , Vertigo/etiology , Adult , Female , Hearing Loss, Conductive/diagnosis , Hearing Loss, Conductive/surgery , Humans , Labor, Obstetric , Pregnancy , Puerperal Disorders/diagnosis , Puerperal Disorders/surgery , Radiography , Semicircular Canals/surgery , Syndrome , Vertigo/diagnostic imaging , Vertigo/surgeryABSTRACT
OBJECTIVE: To characterize presentation, treatment, and outcomes of pediatric retropharyngeal abscess (RPA) and determine optimal treatment. STUDY DESIGN: Retrospective cohort. SUBJECTS AND METHODS: Chart review of 162 pediatric patients with RPA. RESULTS: Initial treatment was surgery in 126 and intravenous antibiotics in 36, of which 17 required surgery. Findings were negative in 30, murky fluid in 34, and pus in 79. Factors predicting positive surgical drainage were duration of symptoms for more than 2 days, prior antibiotic treatment, and CT lesion cross-sectional area >2.0 cm(2). A history of rash was a negative predictor. The mean length of stay (LOS) was 4.8 vs 3.6 days (P = 0.14), and duration of fever (DOF) was 2.5 vs 1.4 days (P = 0.01) for patients with no fluid and fluid at surgery, respectively. For antibiotic vs surgery groups, LOS was 4.4 vs 3.6 days (P = 0.14) and DOF was 2.4 versus 1.5 days (P = 0.0061). CONCLUSIONS: These predictive factors may be useful in selecting patients with retropharyngeal abscesses who might be treated with intravenous antibiotics alone.
Subject(s)
Retropharyngeal Abscess/diagnosis , Adolescent , Age Distribution , Child , Child, Preschool , Drainage , Female , Humans , Infant , Infant, Newborn , Length of Stay , Logistic Models , Male , Retropharyngeal Abscess/epidemiology , Retropharyngeal Abscess/microbiology , Retropharyngeal Abscess/therapy , Retrospective StudiesABSTRACT
PURPOSE: Cancer patients with concurrent comorbid conditions have worse outcomes than patients with no comorbidities. We hypothesized that the prognostic impact of comorbidities would be greatest for patients with cancers associated with a long natural history and least in patients with aggressive cancers. PATIENTS AND METHODS: Using the Barnes-Jewish Hospital Oncology Data Services cancer registry, we grouped 11,558 patients with breast, lung, colon, or prostate cancer by morphologic stage at diagnosis and then determined the 1-year overall survival rate for each group. Overall, severity of comorbidity was assessed from chart review and classified into one of four groups: none, mild, moderate, or severe. The relative prognostic impact of comorbidity was measured by the hazard ratio and adjusted for the prognostic impact of age, race, and sex. RESULTS: One-year overall survival rate ranged from 20% for 1,005 patients with distant spread of lung cancer to 98% for 3,325 patients with localized prostate cancer. Adjusted hazard ratio of moderate/severe comorbidity (relative to none/mild) ranged from 1.04 to 4.48. The correlation between overall survival rate and severity of comorbidity was statistically significant (r2 = 0.56; P < .001). The proportion of variance in outcome explained by comorbidity ranged from less than 1% to almost 9%, depending on tumor site and stage. CONCLUSION: Concurrent comorbidities had the greatest prognostic impact among groups with the highest survival rate and the least impact in groups with the lowest survival rate. These findings can be used to help determine the role comorbidity information should play in studies of cancer outcomes.
Subject(s)
Comorbidity , Neoplasms/mortality , Aged , Breast Neoplasms/mortality , Colonic Neoplasms/mortality , Female , Humans , Lung Neoplasms/mortality , Male , Prognosis , Prostatic Neoplasms/mortality , Severity of Illness Index , Survival RateABSTRACT
Bronchioloalveolar carcinoma of the lung (BAC) is a subtype of adenocarcinoma of the lung. Although traditionally grouped with other non-small cell lung carcinomas (NSCLC), BAC has unique morphological features and clinical behavior such as bilateral lung involvement, indolent course and lack of association with smoking. Some epidemiologic studies report a significant increase in the incidence of BAC. We used the SEER database to compare the incidence, demographics, and overall survival of BAC patients as compared to other NSCLC types over the past two decades (1979-1998). Although the incidence of BAC has increased over the past two decades, BAC represents less than 4% of all NSCLC in every time period evaluated. The 1 year survival rate is significantly better for BAC patients relative to other histological subtypes of NSCLC. There has not been a marked increase in the incidence of BAC reported to SEER over the past 20 years.
